TherapeuticsMD Inc
$ 2.19
0.46%
24 Apr - close price
- Market Cap 25,232,100 USD
- Current Price $ 2.19
- High / Low $ 2.20 / 2.12
- Stock P/E N/A
- Book Value 2.32
- EPS -0.06
- Next Earning Report 2026-05-12
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.04 %
- ROE -0.02 %
- 52 Week High 2.95
- 52 Week Low 0.98
About
TherapeuticsMD, Inc. is a women's healthcare company in the United States. The company is headquartered in Boca Raton, Florida.
Analyst Target Price
$5.00
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-03-27 | 2025-11-12 | 2025-08-12 | 2025-05-08 | 2025-03-27 | 2024-11-12 | 2024-08-12 | 2024-05-10 | 2024-03-29 | 2023-11-14 | 2023-08-14 | 2023-05-15 |
| Reported EPS | 0 | 0 | 0.05 | 0.0219 | 0.0219 | -0.0528 | -0.0945 | -0.0766 | -0.08 | -0.32 | -0.24 | -0.37 |
| Estimated EPS | 0 | 0 | 0 | None | 0.04 | 0.04 | 0.03 | 0.03 | -0.13 | -0.05 | -0.07 | 0.06 |
| Surprise | 0 | 0 | 0.05 | 0 | -0.0181 | -0.0928 | -0.1245 | -0.1066 | 0.05 | -0.27 | -0.17 | -0.43 |
| Surprise Percentage | None% | None% | None% | None% | -45.25% | -232% | -415% | -355.3333% | 38.4615% | -540% | -242.8571% | -716.6667% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-12 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: TXMD
2026-04-23 17:29:00
Shares of TherapeuticsMD Inc. (TXMD) rose 3.32% to $2.18 on Thursday, despite a difficult trading session for the broader stock market. The NASDAQ Composite Index and Dow Jones Industrial Average both closed lower. This gain broke a two-day losing streak for TherapeuticsMD Inc. stock.
2026-04-22 17:33:00
TherapeuticsMD Inc. (TXMD) shares fell 3.21% to $2.11 on Wednesday, marking a second consecutive day of losses despite a positive trading session for the broader market. The NASDAQ Composite Index and the Dow Jones Industrial Average both saw gains, rising 1.64% and 0.69% respectively. This indicates TherapeuticsMD's stock underperformed relative to its competitors and the overall market.
2026-04-20 17:32:00
TherapeuticsMD Inc. (TXMD) stock rose 5.80% to $2.19 on Monday, defying a general market downturn where the NASDAQ Composite and Dow Jones Industrial Average both saw declines. This gain ended a three-day losing streak for the company. The article highlights the stock's strong performance relative to its competitors on a weaker trading day.
2026-04-14 17:30:00
TherapeuticsMD Inc. (TXMD) saw its stock advance 2.93% to $2.11, outperforming the overall market on a positive trading day. The NASDAQ Composite Index and Dow Jones Industrial Average also rose. The company's stock closed 28.47% below its 52-week high.
2026-04-11 00:10:37
TherapeuticsMD, Inc. filed an amended annual report (Form 10-K/A) for the fiscal year ended December 31, 2025, primarily to correct printer errors and update financial schedule details. The company transitioned into a pharmaceutical royalty company in late 2022, deriving revenue from licensing its products like IMVEXXY, BIJUVA, and ANNOVERA, largely through Mayne Pharma. The report also highlights ongoing legal disputes with Mayne Pharma regarding working capital allowances and outlines the company's financial results, showing a reduced net loss for 2025 compared to 2024.
2026-04-09 19:11:01
This article provides financial information for TherapeuticsMD, Inc. (MUN:29TA), specifically focusing on its total debt per share. It is presented in a data-centric format from TradingView, indicating market performance on the Munich Stock Exchange. The content is primarily a data label within the TradingView platform, with no further analytical text.
